CLIP: HealthPartners distributes naloxone nasal spray

In just two weeks, HealthPartners has given naloxone nasal spray – an opioid overdose reversal medication – to more than a hundred people with higher risk for overdose. The plan is expecting to provide the treatment to more than 4,000 people and is hoping distribution will become standard practice with every opioid prescription.